Skip to content

A Comparison Between a Pyrocarbon and a CoCr Shoulder Resurfacing Implant

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01587560
Enrollment
80
Registered
2012-04-30
Start date
2012-01-31
Completion date
2018-01-31
Last updated
2016-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Shoulder

Keywords

Shoulder, Arthroplasty, Pyrocarbon, Randomized controlled trial, Shoulder resurfacing

Brief summary

The purpose of the study is to investigate fixation to bone and the clinical results following shoulder resurfacing arthroplasty. The study will compare results between an implant made of Cobalt-Chrome(CoCr) and an implant made in pyrocarbon.

Interventions

DEVICEPyroTITAN, Ascension Orthopedics, Inc.

All patients will be operated on with a shoulder resurfacing implant. In one arm of the study, the patients will receive an implant made of pyrocarbon. In the second arm, the patients will receive an implant made of Cobalt-Chrome. Aside from the materials, the implant are of the same design.

DEVICETITAN, Ascension Orthopedics, Inc.

Sponsors

Ascension Orthopedics, Inc.
CollaboratorINDUSTRY
Swedish Shoulder and Elbow Arthroplasty Register
CollaboratorUNKNOWN
Karolinska Institutet
CollaboratorOTHER
Danderyd Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Primary or secondary osteoarthritis of the shoulder * Age 40-75 years * Patient capable of giving informed consent * Patient agrees to comply with the study plan

Exclusion criteria

* Destruction of the proximal humerus * Insufficient bone stock * Deficient rotator cuff or earlier failed surgery of the rotator cuff * Large muscle defects or insufficient blood supply in the affected arm * Neuromuscular disorders * Infection, untreated malignancy or transmittable disease preventing the patient from fulfilling the study * Patient unwilling to comply with study regulations * Patient with earlier allergic reaction to pyrocarbon * Patient with known metastatic disease * Patient who has been treated with more than 10 mg corticosteroids (e.g. Prednisone) daily within 3 months from surgery. * Patient participating in other clinical study * Patient in need of glenoid replacement

Design outcomes

Primary

MeasureTime frameDescription
Fixation to bone as measured with radiostereometric analysis (RSA)24 monthsEarly migration of the implants will be measured with RSA at 3, 6, 12 and 24 months.

Secondary

MeasureTime frameDescription
Clinical results after surgery as measured with EuroQol-5D(EQ-5D), American Shoulder and Elbow Surgeons Score(ASES), Constant score, and Western Ontario Osteoarthritis of the Shoulder index(WOOS)24-48 monthsOutcome after surgery will be evaluated using the above mentioned scores performed by and independent and blinded investigator.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026